BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 1665348)

  • 21. IL-2 inhibits proliferation of K562 cells and reduces accumulation of bcr/abl mRNA and oncoprotein.
    Dilloo D; Hanenberg H; Lion T; Burdach S
    Leukemia; 1995 Mar; 9(3):419-24. PubMed ID: 7885040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chronic myeloid leukemia. New prospects for marrow autotransplantation].
    Carella AM; Carlier P; Nati S; Congiu A; Pierluigi D; Raffo MR
    Haematologica; 1991 Jun; 76 Suppl 3():337-51. PubMed ID: 1684348
    [No Abstract]   [Full Text] [Related]  

  • 23. BCR-ABL, ABL-BCR, BCR, and ABL genes are all expressed in individual granulocyte-macrophage colony-forming unit colonies derived from blood of patients with chronic myeloid leukemia.
    Diamond J; Goldman JM; Melo JV
    Blood; 1995 Apr; 85(8):2171-5. PubMed ID: 7718887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia--potential clinical significance.
    Inokuchi K; Yamaguchi H; Tarusawa M; Futaki M; Hanawa H; Tanosaki S; Dan K
    Leukemia; 2002 Feb; 16(2):170-7. PubMed ID: 11840282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-Fluorouracil-resistant CD34+ cell population from peripheral blood of CML patients contains BCR-ABL-negative progenitor cells.
    Jazwiec B; Mahon FX; Pigneux A; Pigeonnier V; Reiffers J
    Exp Hematol; 1995 Dec; 23(14):1509-14. PubMed ID: 8542939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lineage involvement by BCR/ABL in Ph+ lymphoblastic leukemias: chronic myelogenous leukemia presenting in lymphoid blast vs Ph+ acute lymphoblastic leukemia.
    Anastasi J; Feng J; Dickstein JI; Le Beau MM; Rubin CM; Larson RA; Rowley JD; Vardiman JW
    Leukemia; 1996 May; 10(5):795-802. PubMed ID: 8656674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BCR-ABL transcripts detected by polymerase chain reaction (PCR) after allogenic BMT for CML: analysis of 32 longterm disease free patients.
    Guerrasio A; Zaccaria A; Rosso C; Scaravaglio P; Rege Cambrin G; Bertolli VG; Saglio G; Tassinari A; Testoni N; Rosti G
    Bone Marrow Transplant; 1991; 7 Suppl 2():22. PubMed ID: 1878699
    [No Abstract]   [Full Text] [Related]  

  • 28. Retrovirus-mediated gene transfer as an approach to analyze neuroblastoma relapse after autologous bone marrow transplantation.
    Rill DR; Buschle M; Foreman NK; Bartholomew C; Moen RC; Santana VM; Ihle JN; Brenner MK
    Hum Gene Ther; 1992 Apr; 3(2):129-36. PubMed ID: 1391032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of quantitative polymerase chain reaction to monitor residual disease in chronic myelogenous leukemia during treatment with interferon.
    Lion T; Gaiger A; Henn T; Hörth E; Haas OA; Geissler K; Gadner H
    Leukemia; 1995 Aug; 9(8):1353-60. PubMed ID: 7643624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Minimal residual disease status in transplanted chronic myelogenous leukemia patients: low incidence of polymerase chain reaction positive cases among 48 long disease-free subjects who received unmanipulated allogeneic bone marrow transplants.
    Guerrasio A; Martinelli G; Saglio G; Rosso C; Zaccaria A; Rosti G; Testoni N; Ambrosetti A; Izzi T; Sessarego M
    Leukemia; 1992 Jun; 6(6):507-12. PubMed ID: 1602789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The dual expression of minor and major bcr/abl chimeric mRNA in blast crisis of chronic myelogenous leukemia.
    Tanaka M; Yamazaki Y; Hattori M; Tsushita K; Utsumi M; Yoshida S
    Leuk Res; 1996 Jul; 20(7):575-80. PubMed ID: 8795691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rationalizing autotransplant strategies for chronic myeloid leukemia.
    Daley GQ
    Leuk Lymphoma; 1996 May; 21(5-6):353-8. PubMed ID: 9172799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. bcr/abl mRNA detection following bone marrow transplantation for chronic myelogenous leukemia.
    Ely P; Miller WJ
    Transplantation; 1991 Dec; 52(6):1023-8. PubMed ID: 1750065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myeloid mixed chimerism is associated with relapse in bcr-abl positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Román J; Serrano J; Jiménez A; Castillejo JA; Reina ML; González MG; Rodríguez MC; García I; Sánchez J; Maldonado J; Torres A
    Haematologica; 2000 Feb; 85(2):173-80. PubMed ID: 10681725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bcr-abl mRNA expression in patients with chronic myeloproliferative disorders--absence of bcr-abl fused clone except chronic myelocytic leukemia.
    Nakata Y
    Hiroshima J Med Sci; 1993 Jun; 42(2):67-71. PubMed ID: 8253600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.
    Guo JQ; Hirsch-Ginsberg CF; Xian YM; Stass SA; Champlin RE; Giralt SA; McCredie KB; Campbell ML; Arlinghaus RB
    Hematol Pathol; 1993; 7(2):91-106. PubMed ID: 8340287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An approach for the analysis of relapse and marrow reconstitution after autologous marrow transplantation using retrovirus-mediated gene transfer.
    Rill DR; Moen RC; Buschle M; Bartholomew C; Foreman NK; Mirro J; Krance RA; Ihle JN; Brenner MK
    Blood; 1992 May; 79(10):2694-700. PubMed ID: 1316784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retroviral gene transfer to primitive normal and leukemic hematopoietic cells using clinically applicable procedures.
    Hughes PF; Thacker JD; Hogge D; Sutherland HJ; Thomas TE; Lansdorp PM; Eaves CJ; Humphries RK
    J Clin Invest; 1992 Jun; 89(6):1817-24. PubMed ID: 1601991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retroviral mediated gene transfer in chronic myelogenous leukaemia.
    Cornetta K; Moore A; Leemhuis T; Moen RC; Tricot G; Leibowitz D; Hoffman R
    Br J Haematol; 1994 Jun; 87(2):308-16. PubMed ID: 7947272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokine treatment of human bone marrow activates anti-leukaemia effector cells: monitoring of purging by polymerase chain reaction and DNA analysis.
    Dickinson AM; Middleton SL; Latham J; Dunn J; Thomas L; Proctor SJ
    Leukemia; 1995 Mar; 9(3):444-9. PubMed ID: 7533866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.